Compare Ginkgo Bioworks Holdings Inc (DNA) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Matson Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.25 (market cap $505.73M), while Matson Inc trades at $207.76 (market cap $6.11B). The key difference: Matson Inc is far larger — about 12.1× Ginkgo Bioworks Holdings Inc's market cap, and Matson Inc pays a 0.74% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | MATX | |
|---|---|---|
Market Cap | $505.73M | $6.11B |
Sector | Health | Technology |
52-Week High | $16.14 | $223.55 |
52-Week Low | $5.48 | $88.05 |
Enterprise Value | $607.68M | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
